HN2004000525A - Forma de administracion transdermica liquida o semis lida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas - Google Patents
Forma de administracion transdermica liquida o semis lida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletasInfo
- Publication number
- HN2004000525A HN2004000525A HN2004000525A HN2004000525A HN2004000525A HN 2004000525 A HN2004000525 A HN 2004000525A HN 2004000525 A HN2004000525 A HN 2004000525A HN 2004000525 A HN2004000525 A HN 2004000525A HN 2004000525 A HN2004000525 A HN 2004000525A
- Authority
- HN
- Honduras
- Prior art keywords
- light
- administration
- rays
- semi
- stable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
Abstract
LA INVENCION SE RELACIONA CON FORMAS DE ADMINISTRACION FARMACEUTICAS SEMISOLIDAS Y LIQUIDAS PARA USO TRANSDERMICO (TTS) QUE CONTIENEN UNA SUSTANCIA ACTIVA FARMACEUTICA SENSIBLE A LA LUZ EN EL RANGO UV Y POR LO MENOS UNA SUSTANCIA AUXILIAR QUE ABSORBE LUZ UV (ABSORBEDOR UV).INFORMACION ADICIONAL: EL PREPARADO FARMACEUTICO COMPRENDE UNA COMBINACION DE GESTAGENO SELECCIONADO ENTRE GESTODENO O LEVONORGESTREL O UN ESTROGENO COMO EL ETINILESTRADIOL O UN ANDROGENO SELECCIONADO ENTRE TESTOSTERONA, METILTESTOSTERONA, METILNORTESTOSTERONA (MET) O 7ALFA-METIL-11BETA-FLUOR-19-NORTESTOSTERONA (ef-MENT).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03028353A EP1541136A1 (de) | 2003-12-10 | 2003-12-10 | UV-Licht stabile halbfeste transdermale Systeme, die einen lichtempfindlichen Wirkstoff und einen UV-Absorber enthalten |
Publications (1)
Publication Number | Publication Date |
---|---|
HN2004000525A true HN2004000525A (es) | 2010-09-17 |
Family
ID=34486168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HN2004000525A HN2004000525A (es) | 2003-12-10 | 2004-12-10 | Forma de administracion transdermica liquida o semis lida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas |
Country Status (24)
Country | Link |
---|---|
EP (2) | EP1541136A1 (es) |
JP (1) | JP2007534643A (es) |
KR (1) | KR20060096512A (es) |
CN (1) | CN101415402A (es) |
AR (1) | AR047140A1 (es) |
AU (1) | AU2004296539B2 (es) |
BR (1) | BRPI0416979A (es) |
CA (1) | CA2548739C (es) |
CR (1) | CR8461A (es) |
EA (1) | EA010239B1 (es) |
EC (1) | ECSP066689A (es) |
GT (1) | GT200400261A (es) |
HN (1) | HN2004000525A (es) |
IL (1) | IL176208A0 (es) |
MX (1) | MXPA06006534A (es) |
MY (1) | MY141728A (es) |
NO (1) | NO20063208L (es) |
NZ (1) | NZ547733A (es) |
PE (1) | PE20050863A1 (es) |
SV (1) | SV2006001971A (es) |
TW (1) | TW200528136A (es) |
UA (1) | UA85861C2 (es) |
WO (1) | WO2005055975A2 (es) |
ZA (1) | ZA200605632B (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI395806B (zh) | 2010-04-14 | 2013-05-11 | Ind Tech Res Inst | 封裝材料 |
LT2613772T (lt) | 2010-09-06 | 2017-03-27 | Bayer Intellectual Property Gmbh | Mažos dozės transderminiai pleistrai, pasižymintys aktyviu vaisto atpalaidavimu |
US10293023B2 (en) | 2013-03-15 | 2019-05-21 | Children's Medical Center Corporation | Method of altering vascular permeability and uses thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60155111A (ja) * | 1983-10-20 | 1985-08-15 | Hisamitsu Pharmaceut Co Inc | 安定なケトプロフェン含有外用経皮製剤 |
JP2981523B2 (ja) * | 1990-11-19 | 1999-11-22 | 株式会社林原生物化学研究所 | 皮膚外用剤 |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
WO1999008654A1 (en) * | 1997-08-21 | 1999-02-25 | Johnson & Johnson Consumer Companies, Inc. | USE OF 17-α-ESTRADIOL FOR THE TREATMENT OF AGED OR SUNDAMAGED SKIN AND/OR SKIN ATROPHY |
JP2000292428A (ja) * | 1999-04-05 | 2000-10-20 | Umeda Jimusho:Kk | 環境化学物質の内分泌攪乱活性の新規測定方法及びその装置 |
JP2001129566A (ja) * | 1999-11-05 | 2001-05-15 | Mitsubishi Heavy Ind Ltd | 有害物質処理方法およびその装置 |
FR2804024B1 (fr) * | 2000-01-21 | 2002-09-13 | Menarini France | Nouvelles compositions pharmaceutiques a action anti- inflammatoire et leur procede de preparation |
DE10053375C1 (de) * | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
FR2834895B1 (fr) * | 2002-01-22 | 2006-06-23 | Ellipse Pharmaceuticals | Compositions dermatologiques, resistantes a l'eau, avec filtres solaires, procede de fabrication et utilisations de ces compositions |
ITFI20020144A1 (it) * | 2002-08-01 | 2004-02-02 | Menarini Farma Ind | Formulazioni topiche stabilizzate contenenti ketoprofene. |
-
2003
- 2003-12-10 EP EP03028353A patent/EP1541136A1/de not_active Withdrawn
-
2004
- 2004-06-12 UA UAA200607539A patent/UA85861C2/uk unknown
- 2004-12-02 TW TW93137245A patent/TW200528136A/zh unknown
- 2004-12-06 WO PCT/EP2004/013839 patent/WO2005055975A2/de active Application Filing
- 2004-12-06 KR KR1020067013775A patent/KR20060096512A/ko not_active Application Discontinuation
- 2004-12-06 NZ NZ547733A patent/NZ547733A/en unknown
- 2004-12-06 CN CNA2004800369947A patent/CN101415402A/zh active Pending
- 2004-12-06 JP JP2006543451A patent/JP2007534643A/ja active Pending
- 2004-12-06 EA EA200601084A patent/EA010239B1/ru not_active IP Right Cessation
- 2004-12-06 EP EP04803546A patent/EP1703892A2/de not_active Withdrawn
- 2004-12-06 CA CA002548739A patent/CA2548739C/en not_active Expired - Fee Related
- 2004-12-06 AU AU2004296539A patent/AU2004296539B2/en not_active Ceased
- 2004-12-06 BR BRPI0416979-4A patent/BRPI0416979A/pt not_active IP Right Cessation
- 2004-12-10 PE PE2004001228A patent/PE20050863A1/es not_active Application Discontinuation
- 2004-12-10 AR ARP040104604A patent/AR047140A1/es unknown
- 2004-12-10 HN HN2004000525A patent/HN2004000525A/es unknown
- 2004-12-10 SV SV2004001971A patent/SV2006001971A/es not_active Application Discontinuation
- 2004-12-10 GT GT200400261A patent/GT200400261A/es unknown
- 2004-12-10 MY MYPI20045109A patent/MY141728A/en unknown
-
2006
- 2006-06-08 IL IL176208A patent/IL176208A0/en unknown
- 2006-06-08 MX MXPA06006534 patent/MXPA06006534A/es unknown
- 2006-06-16 CR CR8461A patent/CR8461A/es not_active Application Discontinuation
- 2006-07-07 ZA ZA200605632A patent/ZA200605632B/en unknown
- 2006-07-07 EC EC2006006689A patent/ECSP066689A/es unknown
- 2006-07-10 NO NO20063208A patent/NO20063208L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL176208A0 (en) | 2006-10-05 |
GT200400261A (es) | 2005-10-31 |
KR20060096512A (ko) | 2006-09-11 |
ECSP066689A (es) | 2006-10-31 |
EA010239B1 (ru) | 2008-06-30 |
CA2548739C (en) | 2009-08-18 |
UA85861C2 (uk) | 2009-03-10 |
MXPA06006534A (es) | 2006-08-01 |
CN101415402A (zh) | 2009-04-22 |
AR047140A1 (es) | 2006-01-11 |
NZ547733A (en) | 2010-02-26 |
JP2007534643A (ja) | 2007-11-29 |
CR8461A (es) | 2006-12-07 |
TW200528136A (en) | 2005-09-01 |
NO20063208L (no) | 2006-07-10 |
BRPI0416979A (pt) | 2007-02-21 |
MY141728A (en) | 2010-06-15 |
PE20050863A1 (es) | 2005-11-02 |
WO2005055975A2 (de) | 2005-06-23 |
WO2005055975A3 (de) | 2009-03-12 |
EP1703892A2 (de) | 2006-09-27 |
CA2548739A1 (en) | 2005-06-23 |
EP1541136A1 (de) | 2005-06-15 |
SV2006001971A (es) | 2006-02-15 |
AU2004296539B2 (en) | 2008-10-09 |
AU2004296539A1 (en) | 2005-06-23 |
ZA200605632B (en) | 2008-06-25 |
EA200601084A1 (ru) | 2006-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP066674A (es) | Uso extendido de combinación que comprende estrógenos y progestinas | |
ES2165211T3 (es) | Jeringa de inyeccion que incluye un dispositivo para la preparacion de la inyeccion. | |
ES2171283T3 (es) | Sistema de administracion de farmacos para dos o mas substancias activas. | |
UY26496A1 (es) | Composiciones farmacéuticas que proporcionan concentraciones potenciadas de fármaco | |
AR033808A1 (es) | Una composicion topica de anestesia local y los parches y los envases que la contienen | |
CY1116520T1 (el) | Φαρμακοτεχνικη μορφη fulvestrant | |
CR7952A (es) | Sistema terapeutico transdermico estable a los rayos uv | |
CR7611A (es) | Uso de derivados de cilotiocarbamato en tratamiento de condiciones relacionadas con la hormona | |
ES2173945T3 (es) | Uso de antagonistas de aldosterona para inhibir fibrosis miocardiaca. | |
ES2167061T3 (es) | Formas de dosificacion para mejorar la disfuncion erectil en pacientes de sexo masculino. | |
PE20000027A1 (es) | Composiciones cosmeticas con dbs y siliconas funcionalizadas | |
UY28803A1 (es) | Solidos supersaturados estabilizados de drogas lipofílicas | |
AR048185A1 (es) | Sistema de entrega de farmacos constituido por uno o mas compartimentos, que comprende un compuesto progestagenico disuelto en un copolimero de polietileno acetato de vinilo termoplastico | |
UY29701A1 (es) | Formulaciones líquidas para la administración controlada de derivados de bencisoxazol | |
SV2008002527A (es) | Composicion farmaceutica que contiene gestagenos y/o estrogenos y 5-metil-(6s)-tetrahidrofolato ref. p-sv-80.273/ug | |
CY1110637T1 (el) | Διαδερμικο συστημα παραδοσης ορμονων χωρις ενισχυτες διεισδυσης | |
CY1107906T1 (el) | Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου | |
PE20120584A1 (es) | Preparaciones farmaceuticas transdermicas | |
HUP0402213A2 (hu) | Propilénglikolmonokaprilátot tartalmazó szteroid hormontartalmú transzdermális terápiás rendszer | |
ES2190205T3 (es) | Combinacion para el tratamiento de la dependencia del alcohol que contiene un antagonista opioide y un modulador del complejo receptor de nmda. | |
CR10289A (es) | "estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva"(divisional) | |
ES2103493T3 (es) | Uso de parathormona, de sus fragmentos biologicamente activos y de peptidos relacionados para el tratamiento del embarazo. | |
HN2004000525A (es) | Forma de administracion transdermica liquida o semis lida que contiene sustancia activa sensible a la luz, estable a los rayos ultravioletas | |
AR020781A1 (es) | Uso de composicion oftalmica | |
CO5580789A2 (es) | Composicion que comprende una combinacion de un inhibidor de aromatasa, una progestina y un estrogeno y su uso para el tratamiento de endometriosis |